Cargando…
Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways
BACKGROUND: Osteoclast cell increase is a major risk factor for osteoporosis and degenerative bone and joint diseases. At present, RANKL and M-CSF are commonly used to induce osteoclastogenesis. Thioacetamide (TAA) can lead to many types of liver and kidney damage, but less attention has been paid t...
Autores principales: | Jin, XiaoLi, Li, Yang, Yang, Yayang, Shen, Hao, Chen, Jin, Xu, Bin, Xu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800259/ https://www.ncbi.nlm.nih.gov/pubmed/35093114 http://dx.doi.org/10.1186/s13018-022-02938-4 |
Ejemplares similares
-
Acute bone damage through liver-bone axis induced by thioacetamide in rats
por: Jin, Xiaoli, et al.
Publicado: (2022) -
Oridonin Attenuates Thioacetamide-Induced Osteoclastogenesis Through MAPK/NF-κB Pathway and Thioacetamide-Inhibited Osteoblastogenesis Through BMP-2/RUNX2 Pathway
por: Jin, XiaoLi, et al.
Publicado: (2023) -
Icariin attenuates thioacetamide-induced bone loss via the RANKL-p38/ERK-NFAT signaling pathway
por: Cheng, Linyan, et al.
Publicado: (2022) -
Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways
por: Elbaset, Marawan A., et al.
Publicado: (2023) -
Loureirin B downregulates osteoclast differentiation of bone marrow macrophages by targeting the MAPK signaling pathway
por: Zhang, Jiahao, et al.
Publicado: (2022)